NeOnc Reports Third-Quarter 2026 Financial Results
NeOnc Technologies Holdings announced its third-quarter 2026 financial results; the supplied text provides no figures or clinical-progress details.
Related stories
International Seaways Reports Higher Q3 Adjusted Earnings and Revenue
M impact | EQUITY | Nov 05, 2026, 02:26 PM UTC
Kimberly-Clark Q3 Profit Surges, Reaffirms Fiscal Outlook
Kimberly-Clark reported a sharp increase in third-quarter profit, driven largely by a $1.4 billion gain from completing its IFP business transaction.
M impact | EQUITY | Nov 05, 2026, 02:25 PM UTC
Amylyx Pharmaceuticals’ Q3 Net Loss Widens
Amylyx Pharmaceuticals reported a wider net loss for the third quarter.
M impact | EQUITY | Nov 05, 2026, 02:25 PM UTC
Fraser & Neave Holdings Reports Q4 Revenue of RGT 1.19 Billion
M impact | EQUITY | Nov 05, 2026, 02:24 PM UTC
Cronos Reports Lower Third-Quarter Profit Despite Higher Revenue
Cronos said third-quarter profit fell as operating expenses and income tax provision rose, despite increased revenue and record sales in Canada, Germany and Israel for an 11th cons
M impact | EQUITY | Nov 05, 2026, 02:22 PM UTC
Iovance Biotherapeutics Reports Third-Quarter Revenue of $121.47 Million
Third-quarter revenue increased 80% year over year, while net loss narrowed 76%. Higher Amtagvi infusions, corresponding Proleukin sales and price increases drove revenue growth; l
M impact | EQUITY | Nov 05, 2026, 02:21 PM UTC